129Xe MRI Cardiopulmonary
Recruiting
Phase 2
Interventional Study
Interstitial Lung Disease
Chronic Thromboembolic Pulmonary Hypertension
Acute Pulmonary Embolism
Anemia
Polycythemia
Dyspnea
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 125 (estimated)
- Sponsor
- Bastiaan Driehuys · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to interventions.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria for Healthy Volunteers:
(Inclusion Criteria: Subjects must meet all of the following inclusion criteria to be eligible for enrollment into the trial)
1. Outpatients of either gender, age \> 18
2. Willing and able to give informed consent and adhere to visit/protocol (Consent mus…
Contacts